March 1, 2012
Bookmark and Share  




In this week's Eblast we offer the following new postings:

  • March 2012 HCV Advocate Newsletter—this month’s issue features the following articles:

    • HCV PI Therapy for HIV/HCV Coinfection, by Alan Franciscus—read about the recommendations for use of the Victrelis (boceprevir) and Incivek (telaprevir) plus PEG/RBV triple therapies for treating chronic hepatitis C in people who are also infected with HIV.  Included in this article is important information about the drug-drug interactions between HIV medications and the new HCV protease inhibitors.

    • HCV Snapshots, by Lucinda Porter, RN, and Alan Franciscus—in this month’s column we write about HCV and the brain, treating HCV patients who drink alcohol, combination therapy with daclatasvir/asunaprevir plus PEG/RBV, increase in liver cancer rates, the benefits of Vitamin D, ‘normal’ ALT levels, and the risk of transmitting HCV through tattooing and piercing.

    • HealthWise:  Part 2 of Searching for Supplements, by Lucinda Porter, RN—Lucinda continues her discussion on supplements and HCV.

    • Disability and Benefits: Taxation of Disability Benefits, by Jacques Chambers, CLU—in this month’s column Jacques lays out the information you need to know about taxation of disability payments. 


  • New HCSP Fact Sheet series – we have updated information and reformatted some of our fact sheets. Check out the Extrahepatic Manifestations section and some other fact sheets that have been recently revised and reformatted.

  • HBV Journal Review, by Christine Kukka—This month’s review features important news and journal articles—how HBV and HCV deaths have surpassed HIV deaths, treating immune-tolerant hepatitis B, the benefits of incorporating fish and fatty acids into the diet to help decrease the risk of liver cancer, the protective effects of estrogen, and much, much more. 


HBV and HCV Blog:
Read about the latest and greatest in the news


Yours Truly,




Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate
Editor-in-Chief, HBV Advocate


**Questions and Comments: Questions and/or comments can be directed to

**To receive the eblast in your email inbox simply send an e-mail to: with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.